Est. 2001·3,000+ placements · six offices · four regions
Capital Raisingcurated sourcedetected 2026-04-14 · confidence 95%

Last updated

Modus: Capital Raising

Modus raised $85M in Series A from Lightspeed Venture Partners for AI-native audit platform automating complex audit procedures.

Source: PostRound — weekly Series A log

What happened
Modus raised $85M in Series A from Lightspeed Venture Partners for AI-native audit platform automating complex audit procedures.
Who
Modus · USA
When
2026-04-14
So what
Modus has taken on $85M at Series A to do something accounting firms have resisted automating for decades: the complex, judgment-intensive procedures at the core of an audit engagement, sampling, control testing, evidence evaluation.

The leadership read

Modus has taken on $85M at Series A to do something accounting firms have resisted automating for decades: the complex, judgment-intensive procedures at the core of an audit engagement, sampling, control testing, evidence evaluation. A raise at this size, at this stage, is not product-market-fit capital; it is go-to-market and integration capital. Modus has effectively committed to embedding inside the workflow of regulated professional-services firms, which means it now operates against procurement cycles, liability frameworks, and partner-approval processes that most SaaS companies never encounter at Series A. The operational reality has shifted from proof-of-concept to compliance-grade deployment at scale. The related signals we have tracked over the last 90 days are heavily weighted toward capital formation rather than AI-vertical-specific comparable rounds, the 12 signals span infrastructure, healthtech, and energy, with Ellis AI (private credit AI, $10M seed) as the closest functional analog in AI-for-regulated-professional-services. The Modus raise stands out within the batch precisely because $85M at Series A for an AI audit platform implies Lightspeed is treating the professional-services automation category as winner-take-most and moving early. That thesis is consistent with the broader pattern of large early-stage AI bets concentrating in sectors where data is scarce, workflows are auditable, and switching costs are high. Companies at this stage of deployment into regulated professional-services corridors face rising demand for functional leadership at the intersection of enterprise sales and compliance, specifically, commercial operators who understand partnership-based selling into accounting firm networks, product leaders fluent in audit-standard frameworks (PCAOB, IAASB), and risk and regulatory affairs capacity that can credibly engage with standard-setters as AI enters attestation workflows.

Market context: Against a Talent Market Index of 122.7 (Hot) (up 17.8 month-on-month), Americas is at rising (+34.4pts) on signal share.

Modus: 0 signals in the last 90 days.

MitchelLake in this thematic

More signals across Americas

Capital Raising · Americas

Antheia →

Antheia, an advanced biosynthesis pharmaceutical manufacturer, secured an $80 million conditional funding commitment from the Department of War's Office of Strategic Capital to support domestic onshoring of critical medicine supply chains.

Capital Raising · Americas

Klook Technology →

Hong Kong-based travel booking platform Klook Technology has filed to withdraw its US IPO, which it had filed for in November 2025.

Capital Raising · Americas

Strive →

Strive priced an upsized $630M IPO of SATS preferred stock.

Capital Raising · Americas

Swamp Club →

San Francisco-based AI agent platform Swamp Club raised a $7M seed round led by Amplify Partners, with Encoded Ventures and angels participating. Funds will scale its behavior-centric AI agent platform for enterprise production use.

Capital Raising · Americas

EMode Photonix →

Boulder, Colorado photonics simulation software startup EMode Photonix raised a $1M pre-seed round led by Ground State Ventures, with Harlow Capital Management participating.

Capital Raising · Americas

Frazier Life Sciences Acquisition Corp →

Frazier Life Sciences is taking a biotech-focused SPAC public on Nasdaq, a blank-check vehicle raising capital to acquire a life sciences company.

Where this lands in our work

Weekly briefing

Track companies like Modus — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record